Basic Science Catalyzing Treatments for Glaucoma

青光眼的基础科学催化治疗

• 批准号: 9391815
• 负责人: W Daniel Stamer
• 金额: $ 2.41万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-01 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9391815
• 关键词: Academia; Area; Award; Back; Basic Science; Blindness; Cellular biology; Clinical; Clinical Research; Collaborations; Development; Diagnosis; Disease; Disease Progression; Doctor of Medicine; Doctor of Philosophy; Environment; Ethnic group; Eye; Feedback; Fellowship; Foundations; Functional disorder; Funding; Future; Gene Mutation; Glaucoma; Goals; Homeostasis; Individual; Industry; Institution; International; Knowledge; Learning; Location; Mind; Molecular; Monitor; Morehouse School of Medicine; Natural regeneration; Ophthalmologist; Optic Disk; Participant; Pathogenesis; Pathology; Patient Care; Patients; Physiologic Intraocular Pressure; Public Health; Recording of previous events; Recruitment Activity; Research; Research Personnel; Resources; Retinal Ganglion Cells; Scientist; Secure; Senior Scientist; Societies; Structure; Students; Therapeutic; Tissues; Translating; Translational Research; Translations; Travel; Underrepresented Minority; Universities; Vision; Woman; Work; career; career development; cell injury; educational atmosphere; ethnic diversity; imaging modality; interest; lectures; meetings; neuroprotection; new technology; novel; posters; role model; social; student participation; symposium; translational impact

Summary This proposal seeks support for the 2017 International Society for Eye Research (ISER)-BrightFocus Foundation (BFF) glaucoma meeting titled "Basic Science Catalyzing Treatments for Glaucoma" to be held October 5th – 7th, 2017 in Atlanta, Georgia at the Emory Conference Center Hotel. As with the inaugural meeting that was held in Sarasota, FL in 2013, the goal of this meeting is to bring together basic scientists, clinician-scientists, students and fellows for presentations and in-depth discussions on the molecular mechanisms that underlie glaucomatous pathology, both at the level of the conventional outflow tract and optic nerve head. Additionally, novel technologies developed (i) to diagnose and monitor disease progression, (ii) modify/restore glaucomatous dysfunction and (ii) regenerate damaged cells/tissues will be presented. We have already recruited 6 thought leaders in glaucoma to give keynote lectures at the conference. As with the first meeting, the eleven platform sessions will be selected exclusively from submitted abstracts. We have reserved one of the platform sessions and we are putting on a one-day "crash course" in glaucoma exclusively for junior investigators, consistent with our goal of increasing student and junior investigator participation. ISER and BFF have an established history for promoting diversity, and the speakers that are selected from abstracts will represent a diverse group of scientists that includes women and underrepresented individuals. The Specific Aims of the conference are: 1. To enhance the emerging careers of 22 young scientists (including women and underrepresented minorities) in glaucoma and increase student participation in the meeting by providing travel awards. 2. To provide a forum for dissemination of the most recent advances in the state of knowledge on glaucoma. 3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. 4. To bring together scientists working in disparate areas of glaucoma research. We anticipate that this meeting will provide useful information on recent advances in glaucoma and will serve as an important resource for those involved in the translation of these findings into suitable therapeutics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 12 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not have the resources to attend this focused meeting.

概括 该提案寻求支持2017年国际眼睛研究学会（ISER）-brightfocus 基金会（BFF）青光眼会议，标题为“基础科学催化青光眼疗法” 2017年10月5日至7日在佐治亚州亚特兰大举行的埃默里会议中心酒店。与就职典礼一样 2013年在佛罗里达州萨拉索塔举行的会议，这次会议的目标是将基础科学家汇集在一起 临床科学家，学生和研究员，以进行分子的演讲和深入讨论 在常规出口段的水平和 视神经头。此外，开发了新技术来诊断和监测疾病 进展，（ii）修改/恢复青光眼功能障碍，（ii）再生受损的细胞/组织 提出。我们已经招募了6位青光眼的6位思想领袖，在 会议。与第一次会议一样，将专门从 提交的摘要。我们保留了一个平台会议，我们正在为期一天的“崩溃” 课程“专门针对初级调查人员的青光眼，这与我们增加学生和增加的目标一致 初级调查员参与。 Iser和BFF具有促进多样性的既定历史，而 从摘要中选出的演讲者将代表包括女性在内的科学家的潜水者群体 和代表性不足的个人。 会议的具体目的是： 1。提高22位年轻科学家的新兴职业（包括妇女和人为不足 少数民族）在青光眼中，通过提供旅行奖来增加学生参加会议的参与。 2。提供一个论坛来传播有关知识状态的最新进展 青光眼。 3。创建一个可以促进基本和临床之间新思想交流的环境 科学家并为所有种族和社会的视觉科学家带来机会 背景会议和建立研究合作。 4。将在青光眼研究不同领域工作的科学家聚集在一起。 我们预计这次会议将提供有关青光眼最新进展的有用信息，并将服务 作为参与这些发现转化为合适治疗剂的人的重要资源。 这次会议还将提供新的机会，新发现的途径，以及一个发展论坛 与会者之间的潜在合作。要求的资金将支持旅行，住宿 以及12名学生（博士后和博士后）和10名初级调查人员的注册 有资源参加这次重点会议。